Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:MRK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMRKMerck & Co., Inc.$80.28+5.7%$85.27$73.57▼$134.63$201.58B0.4312.22 million shs21.75 million shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMRKMerck & Co., Inc.0.00%-8.73%-4.12%-12.30%-41.66%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMRKMerck & Co., Inc.4.9963 of 5 stars3.33.05.03.94.12.53.8Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMRKMerck & Co., Inc. 2.59Moderate Buy$111.1338.43% UpsideCurrent Analyst Ratings BreakdownLatest SDRY, FCCN, TED, and MRK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/22/2025MRKMerck & Co., Inc.Cantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$85.004/17/2025MRKMerck & Co., Inc.GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$115.00 ➝ $115.002/18/2025MRKMerck & Co., Inc.Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$128.00 ➝ $105.002/12/2025MRKMerck & Co., Inc.GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$122.00 ➝ $115.00(Data available from 5/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMRKMerck & Co., Inc.$63.92B3.15$2.79 per share28.82$14.85 per share5.41Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMRKMerck & Co., Inc.$17.12B$6.8711.938.110.7726.67%45.35%17.36%7/29/2025 (Estimated)Latest SDRY, FCCN, TED, and MRK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/24/2025Q1 2025MRKMerck & Co., Inc.$2.16$2.22+$0.06$2.01$15.59 billion$15.53 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMRKMerck & Co., Inc.$3.244.04%+5.73%47.16%14 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMRKMerck & Co., Inc.0.791.361.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMRKMerck & Co., Inc.76.07%Insider OwnershipCompanyInsider OwnershipMRKMerck & Co., Inc.0.13%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMRKMerck & Co., Inc.69,0002.51 billion2.53 billionOptionableSDRY, FCCN, TED, and MRK HeadlinesRecent News About These CompaniesPharma Stocks Hit by Trump's Vow to Cut US Prescription Drug CostsMay 12 at 10:41 AM | zacks.comSurprise Breakthrough: US-China Talks Spark Market RallyMay 12 at 10:00 AM | zacks.comInvestment Management Corp of Ontario Sells 47,839 Shares of Merck & Co., Inc. (NYSE:MRK)May 12 at 8:23 AM | marketbeat.comInvestor s Fiduciary Advisor Network LLC Invests $3.40 Million in Merck & Co., Inc. (NYSE:MRK)May 12 at 8:22 AM | marketbeat.comJacobs Levy Equity Management Inc. Reduces Stock Position in Merck & Co., Inc. (NYSE:MRK)May 12 at 8:06 AM | marketbeat.comJanus Henderson Group PLC Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)May 12 at 8:05 AM | marketbeat.comK2 Principal Fund L.P. Buys Shares of 13,032 Merck & Co., Inc. (NYSE:MRK)May 12 at 7:45 AM | marketbeat.comKahn Brothers Group Inc. Has $50.63 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK)May 12 at 7:45 AM | marketbeat.comHumankind Investments LLC Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)May 12 at 7:27 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Acquired Rep. Robert Bresnahan, Jr.May 12 at 2:05 AM | americanbankingnews.comJeito Capital Strengthens Leadership for Next Chapter of Growth: Mehdi Ainouche Promoted to Partner, Julien Elric to Senior PrincipalMay 12 at 1:00 AM | globenewswire.comRep. Robert Bresnahan, Jr. Purchases Shares of Merck & Co., Inc. (NYSE:MRK)May 11 at 11:03 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Sets New 1-Year Low - Here's WhyMay 11 at 6:45 AM | marketbeat.comGotham Asset Management LLC Has $42.28 Million Holdings in Merck & Co., Inc. (NYSE:MRK)May 11 at 6:43 AM | marketbeat.comFocus Partners Wealth Purchases 14,163 Shares of Merck & Co., Inc. (NYSE:MRK)May 11 at 6:25 AM | marketbeat.comFreedom Together Foundation Sells 54,000 Shares of Merck & Co., Inc. (NYSE:MRK)May 11 at 6:16 AM | marketbeat.comFred Alger Management LLC Has $951,000 Stock Holdings in Merck & Co., Inc. (NYSE:MRK)May 11 at 6:03 AM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Unloaded Rep. Jefferson ShreveMay 11 at 5:01 AM | marketbeat.comRep. Jefferson Shreve Sells Merck & Co., Inc. (NYSE:MRK) StockMay 11 at 2:05 AM | americanbankingnews.comMerck & Co., Inc. (NYSE:MRK) Trading Up 0.4% - Here's WhyMay 10 at 2:34 PM | marketbeat.com3,393 Shares in Merck & Co., Inc. (NYSE:MRK) Purchased by Elefante Mark BMay 10 at 8:23 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesJoby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinCongress! Who Traded What During the Tariff-Induced Meltdown By Thomas Hughes | April 15, 2025View Congress! Who Traded What During the Tariff-Induced Meltdown UPS Stock Forecast: Rebound Underway for United Parcel Service?By Thomas Hughes | May 4, 2025View UPS Stock Forecast: Rebound Underway for United Parcel Service?Time to Buy Alibaba and PDD After Tariff Exemptions?By Gabriel Osorio-Mazilli | April 17, 2025View Time to Buy Alibaba and PDD After Tariff Exemptions?Qualcomm Stock Just Earned a Fresh Buy Rating—Get ExcitedBy Sam Quirke | April 16, 2025View Qualcomm Stock Just Earned a Fresh Buy Rating—Get ExcitedSDRY, FCCN, TED, and MRK Company DescriptionsMerck & Co., Inc. NYSE:MRK$80.28 +4.31 (+5.67%) Closing price 03:59 PM EasternExtended Trading$80.38 +0.10 (+0.12%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs 5 Reasons the Rebound in Microchip Technology Stock Is Real Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
